Go Pro
→ Do this before December or regret it (From Porter & Company) (Ad)tc pixel Free ONTO Stock Alerts

Onto Innovation (ONTO) Financials

Onto Innovation logo
$280.94 +12.02 (+4.47%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$283.50 +2.56 (+0.91%)
As of 09/11/2026 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Onto Innovation

Annual Income Statements for Onto Innovation

This table shows Onto Innovation's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Income / (Loss) Attributable to Common Shareholders		 2.91 44 33 45 1.91 31 142 223 121 202 137
Consolidated Net Income / (Loss)		 2.91 44 33 45 1.91 31 142 223 121 202 137
Net Income / (Loss) Continuing Operations		 2.91 44 33 45 1.91 31 142 223 121 202 137
Total Pre-Tax Income 		5.57 29 60 53 -0.60 -27 156 242 133 220 163
Total Operating Income		 4.97 29 59 51 -5.04 -27 156 237 116 187 133
Total Gross Profit		 90 114 135 148 135 278 429 539 420 515 500
Total Revenue		 187 221 255 274 306 556 789 1,005 816 987 1,005
Operating Revenue		 187 221 255 274 306 556 789 1,005 816 987 1,005
Total Cost of Revenue		 98 107 121 126 171 278 360 466 396 472 505
Operating Cost of Revenue		 98 107 121 126 171 278 360 466 396 472 505
Total Operating Expenses		 85 85 75 97 140 252 273 303 304 328 367
Selling, General & Admin Expense		 22 23 28 34 53 65 68 70 80 80 107
Marketing Expense		 28 30 21 22 28 48 57 66 62 76 70
Research & Development Expense		 33 31 38 40 48 85 96 112 104 114 132
Amortization Expense		 0.11 0.02 1.94 1.53 10 54 51 55 55 49 39
Other Operating Expenses / (Income)		 - - - - - - - - 3.57 9.01 18
Total Other Income / (Expense), net		 0.60 0.04 0.51 2.26 4.45 0.19 -0.73 4.87 17 33 30
Interest & Investment Income		 0.07 0.04 0.97 2.21 3.67 2.90 1.16 5.01 20 33 35
Other Income / (Expense), net		 0.81 0.29 -0.46 0.06 0.78 -2.71 -1.89 -0.14 -3.85 -0.15 -5.00
Income Tax Expense		 2.66 -15 27 8.25 -2.51 -4.16 13 18 11 19 26
Basic Earnings per Share		 $0.12 $1.79 $1.30 $1.77 $0.06 $0.63 $2.89 $4.52 $2.47 $4.09 $2.78
Weighted Average Basic Shares Outstanding		 24.06M 24.66M 25.33M 25.47M 29.73M 49.14M 49.24M 49.42M 48.97M 49.34M 49.12M
Diluted Earnings per Share		 $0.12 $1.75 $1.27 $1.74 $0.06 $0.63 $2.86 $4.49 $2.46 $4.06 $2.78
Weighted Average Diluted Shares Outstanding		 24.38M 25.15M 25.87M 25.90M 30.01M 49.48M 49.73M 49.76M 49.32M 49.66M 49.27M
Weighted Average Basic & Diluted Shares Outstanding		 24.20M 24.60M 25.40M 24.10M 50.28M 48.88M 49.36M 48.75M 49.13M 49.27M 49.70M

Quarterly Income Statements for Onto Innovation

This table shows Onto Innovation's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 30 47 53 53 49 64 34 28 11 34 60
Consolidated Net Income / (Loss)		 30 47 53 53 49 64 34 28 11 34 60
Net Income / (Loss) Continuing Operations		 30 47 53 53 49 64 34 28 11 34 60
Total Pre-Tax Income 		34 51 57 61 51 72 40 32 20 38 68
Total Operating Income		 28 43 49 53 42 63 32 24 14 34 64
Total Gross Profit		 108 118 128 136 132 143 122 111 124 146 183
Total Revenue		 219 229 242 252 264 267 254 218 267 292 343
Operating Revenue		 219 229 242 252 264 267 254 218 267 292 343
Total Cost of Revenue		 111 111 114 118 132 123 138 112 133 151 164
Operating Cost of Revenue		 111 111 114 118 132 123 138 112 133 151 164
Total Operating Expenses		 80 76 79 81 90 80 84 83 120 108 116
Selling, General & Admin Expense		 27 18 20 20 26 23 25 25 34 31 34
Marketing Expense		 15 18 19 19 19 20 15 17 18 21 23
Research & Development Expense		 24 27 27 28 35 28 35 32 36 35 39
Amortization Expense		 13 13 13 13 10 8.45 8.45 8.45 14 20 20
Total Other Income / (Expense), net		 5.60 8.15 8.44 7.94 8.81 8.52 7.49 8.29 5.67 4.54 4.95
Interest & Investment Income		 6.46 7.36 8.50 8.67 8.97 9.27 8.63 9.29 7.78 5.10 5.25
Other Income / (Expense), net		 -0.86 0.79 -0.06 -0.72 -0.15 -0.74 -1.14 -1.00 -2.12 -0.56 -0.30
Income Tax Expense		 3.52 4.04 4.32 7.96 2.45 7.56 5.83 3.76 9.00 4.30 8.39
Basic Earnings per Share		 $0.61 $0.95 $1.07 $1.07 $1.00 $1.30 $0.69 $0.58 $0.21 $0.68 $1.22
Weighted Average Basic Shares Outstanding		 48.97M 49.23M 49.34M 49.43M 49.34M 49.18M 48.93M 49.02M 49.12M 49.74M 49.41M
Diluted Earnings per Share		 $0.61 $0.94 $1.07 $1.07 $0.98 $1.30 $0.69 $0.57 $0.22 $0.67 $1.21
Weighted Average Diluted Shares Outstanding		 49.32M 49.64M 49.67M 49.69M 49.66M 49.41M 49.02M 49.11M 49.27M 50.00M 49.68M
Weighted Average Basic & Diluted Shares Outstanding		 49.13M 49.28M 49.38M 49.39M 49.27M 48.87M 49.00M 49.01M 49.70M 49.74M 49.07M

Annual Cash Flow Statements for Onto Innovation

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Change in Cash & Equivalents		 3.48 8.91 30 45 18 -52 33 24 58 -21 133
Net Cash From Operating Activities		 1.57 46 64 35 18 106 175 137 172 246 328
Net Cash From Continuing Operating Activities		 1.57 46 64 35 18 50 175 148 172 246 328
Net Income / (Loss) Continuing Operations		 2.91 44 33 45 1.91 31 142 223 121 202 137
Consolidated Net Income / (Loss)		 2.91 44 33 45 1.91 31 142 223 121 202 137
Depreciation Expense		 9.08 8.30 3.99 4.85 5.97 14 14 9.38 12 13 21
Amortization Expense		 - - 1.94 1.53 26 64 52 55 50 42 35
Non-Cash Adjustments To Reconcile Net Income		 9.02 11 9.87 11 24 37 30 40 39 53 63
Changes in Operating Assets and Liabilities, net		 -19 -17 15 -27 -39 -97 -63 -180 -50 -64 73
Net Cash From Investing Activities		 1.95 -42 -33 34 4.10 49 -142 -56 -103 -227 -122
Net Cash From Continuing Investing Activities		 1.95 -42 -33 34 4.10 -49 -142 -56 -103 -227 -122
Purchase of Property, Plant & Equipment		 -1.85 -4.00 -10 -7.54 -6.80 -3.83 -12 -18 -23 -32 -29
Acquisitions		 - 0.00 -1.00 - 0.00 0.00 -24 -4.64 0.00 -27 -436
Purchase of Investments		 -41 -83 -165 -140 -127 -313 -361 -371 -480 -709 -476
Sale of Property, Plant & Equipment		 - 0.00 - - - - 0.00 0.00 2.80 0.00 0.00
Sale and/or Maturity of Investments		 45 45 143 186 94 265 255 339 397 541 827
Other Investing Activities, net		 - - 0.00 -5.00 0.00 2.85 - - 0.00 0.00 -8.00
Net Cash From Financing Activities		 0.22 5.27 -2.55 -24 -4.20 -54 2.67 -68 -9.48 -36 -75
Net Cash From Continuing Financing Activities		 0.22 5.27 -2.55 -24 -4.20 -54 2.67 -68 -9.48 -36 -75
Repurchase of Common Equity		 -1.72 0.00 -1.03 -21 -0.74 -52 0.00 -65 -3.20 -25 -75
Issuance of Common Equity		 3.97 8.45 0.62 0.62 0.84 2.92 10 8.07 5.29 9.18 13
Other Financing Activities, net		 -1.18 -2.86 -2.15 -3.46 -4.30 -4.62 -7.40 -11 -12 -20 -14
Effect of Exchange Rate Changes		 -0.26 0.08 0.81 -0.34 0.23 - - - - - 1.58
Cash Income Taxes Paid		 -0.83 3.77 15 4.30 -3.85 0.00 24 59 34 36 36

Quarterly Cash Flow Statements for Onto Innovation

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 51 -43 -18 16 24 -9.22 14 386 -257 -94 1,247
Net Cash From Operating Activities		 62 57 65 67 56 92 58 83 95 26 62
Net Cash From Continuing Operating Activities		 84 57 65 67 56 92 58 83 95 26 218
Net Income / (Loss) Continuing Operations		 30 47 53 53 49 64 34 28 11 34 60
Consolidated Net Income / (Loss)		 30 47 53 53 49 64 34 28 11 34 60
Depreciation Expense		 3.37 3.39 3.53 3.90 2.05 4.40 5.84 4.94 5.86 5.78 5.83
Amortization Expense		 13 12 13 13 10 6.91 6.95 7.18 14 19 21
Non-Cash Adjustments To Reconcile Net Income		 9.49 7.99 9.85 9.81 25 9.52 27 9.10 18 8.88 11
Changes in Operating Assets and Liabilities, net		 28 -13 -14 -13 -30 7.06 -16 34 47 -42 119
Net Cash From Investing Activities		 -37 -92 -74 -57 -4.10 -22 -43 297 -353 -113 -230
Net Cash From Continuing Investing Activities		 -37 -92 -74 -57 -4.10 -22 -43 297 -353 -113 -230
Purchase of Property, Plant & Equipment		 -2.46 -6.98 -12 -8.05 -4.63 -8.23 -14 -1.38 -5.13 -3.59 -3.66
Purchase of Investments		 -120 -208 -187 -143 -171 -209 -211 -1.84 -55 -180 -473
Sale and/or Maturity of Investments		 83 123 125 95 198 203 182 300 142 70 246
Net Cash From Financing Activities		 -0.39 -5.07 -8.87 3.95 -26 -80 -3.71 5.36 2.71 -6.70 1,170
Net Cash From Continuing Financing Activities		 -0.39 -5.07 -8.87 3.95 -26 -80 -3.71 5.36 2.71 -6.70 1,259
Repurchase of Common Equity		 - 0.00 - - -25 -75 - - - 0.00 -205
Issuance of Common Equity		 - 4.02 -0.00 5.16 - 4.18 - 5.56 3.66 0.00 5.93
Other Financing Activities, net		 -0.39 -9.09 -8.87 -1.22 -0.60 -8.68 -3.71 -0.20 -0.95 -6.70 -12
Cash Income Taxes Paid		 5.17 0.92 21 8.71 5.27 0.77 32 2.83 0.57 1.57 3.55

Annual Balance Sheets for Onto Innovation

This table presents Onto Innovation's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/30/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Total Assets		 236 288 310 418 1,449 1,468 1,650 1,795 1,910 2,117 2,368
Total Current Assets		 178 216 240 351 642 732 948 1,135 1,283 1,478 1,268
Cash & Equivalents		 38 47 35 112 131 137 170 176 234 213 346
Short-Term Investments		 45 83 82 63 190 237 342 372 464 639 294
Accounts Receivable		 38 39 62 64 124 149 177 241 227 308 269
Inventories, net		 51 41 54 97 176 191 243 324 328 287 298
Prepaid Expenses		 6.59 5.67 6.23 15 22 17 16 21 31 30 61
Plant, Property, & Equipment, net		 44 44 45 19 98 88 82 92 104 124 127
Total Noncurrent Assets		 13 27 25 48 708 649 620 568 523 516 973
Goodwill		 9.42 8.94 10 22 307 307 316 316 316 330 644
Intangible Assets		 1.87 0.41 2.21 7.45 372 318 277 222 167 127 298
Noncurrent Deferred & Refundable Income Taxes		 1.12 17 12 13 1.46 2.24 4.82 4.78 19 43 3.86
Other Noncurrent Operating Assets		 0.53 0.47 0.41 5.51 28 21 22 25 21 15 27
Total Liabilities & Shareholders' Equity		 236 288 310 418 1,449 1,468 1,650 1,795 1,910 2,117 2,368
Total Liabilities		 48 44 47 56 185 203 224 198 173 191 267
Total Current Liabilities		 45 42 44 45 86 120 155 161 148 170 219
Accounts Payable		 12 11 14 17 28 40 53 55 50 56 108
Accrued Expenses		 - - - 14 26 37 43 49 42 50 49
Current Deferred Revenue		 13 9.17 7.41 6.77 13 14 30 30 25 34 32
Other Current Liabilities		 8.88 8.05 7.25 7.54 19 28 28 27 31 30 31
Total Noncurrent Liabilities		 3.00 2.03 3.22 11 99 83 69 38 25 21 48
Long-Term Debt		 - - - - - - - - - - 0.00
Noncurrent Deferred & Payable Income Tax Liabilities		 0.52 0.02 0.18 0.00 67 56 40 7.37 0.00 0.00 20
Other Noncurrent Operating Liabilities		 0.88 0.35 0.52 11 32 28 29 31 25 21 28
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Total Preferred & Common Equity		 187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Total Common Equity		 187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Common Stock		 259 272 255 370 1,269 1,234 1,256 1,244 1,262 1,275 1,367
Retained Earnings		 -66 -22 9.11 -6.77 -4.86 26 169 363 482 665 744
Accumulated Other Comprehensive Income / (Loss)		 -5.20 -6.05 -2.12 -1.26 -0.60 4.57 1.32 -10 -7.90 -14 -10

Quarterly Balance Sheets for Onto Innovation

This table presents Onto Innovation's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 4/1/2023 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 3/31/2026 6/30/2026
Total Assets		 1,803 1,821 1,862 1,953 2,005 2,073 2,115 2,140 2,187 2,396 3,699
Total Current Assets		 1,155 1,183 1,221 1,333 1,385 1,458 1,469 1,494 1,545 1,320 2,642
Cash & Equivalents		 230 224 207 191 173 189 204 217 603 252 1,253
Short-Term Investments		 353 385 423 550 613 667 647 677 381 402 629
Accounts Receivable		 210 188 210 232 238 254 292 285 260 307 337
Inventories, net		 338 352 346 330 320 308 293 270 259 316 379
Prepaid Expenses		 24 34 36 31 42 41 34 44 41 43 43
Plant, Property, & Equipment, net		 98 100 104 107 115 120 127 133 129 124 124
Total Noncurrent Assets		 550 538 537 514 505 495 519 513 513 953 933
Goodwill		 316 316 316 316 316 316 330 330 330 643 643
Intangible Assets		 208 195 181 154 141 128 119 111 102 278 259
Noncurrent Deferred & Refundable Income Taxes		 4.79 8.32 18 24 29 35 47 50 57 4.45 4.41
Other Noncurrent Operating Assets		 21 19 22 19 18 17 23 22 23 27 27
Total Liabilities & Shareholders' Equity		 1,803 1,821 1,862 1,953 2,005 2,073 2,115 2,140 2,187 2,396 3,699
Total Liabilities		 178 164 166 172 174 170 195 177 185 264 1,776
Total Current Liabilities		 148 137 136 147 148 145 174 156 163 214 272
Accounts Payable		 54 50 44 56 51 48 55 38 53 106 139
Accrued Expenses		 38 36 39 35 40 44 42 50 49 46 55
Current Deferred Revenue		 28 24 23 26 28 27 39 39 31 31 36
Other Current Liabilities		 29 27 29 30 28 26 38 29 30 31 41
Total Noncurrent Liabilities		 30 27 30 25 25 25 21 21 22 50 1,505
Long-Term Debt		 - - - - - - - - - - 1,472
Noncurrent Deferred & Payable Income Tax Liabilities		 1.74 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 20 2.10
Other Noncurrent Operating Liabilities		 28 27 30 25 25 25 21 21 22 29 31
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,625 1,657 1,696 1,782 1,832 1,904 1,920 1,963 2,002 2,132 1,923
Total Preferred & Common Equity		 1,625 1,657 1,696 1,782 1,832 1,904 1,920 1,963 2,002 2,132 1,923
Total Common Equity		 1,625 1,657 1,696 1,782 1,832 1,904 1,920 1,963 2,002 2,132 1,923
Common Stock		 1,242 1,251 1,257 1,263 1,263 1,275 1,260 1,263 1,275 1,367 1,098
Retained Earnings		 390 416 452 529 582 635 671 705 733 778 838
Accumulated Other Comprehensive Income / (Loss)		 -7.53 -11 -13 -11 -13 -6.33 -12 -4.75 -6.42 -13 -13

Annual Metrics And Ratios for Onto Innovation

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
DEI Shares Outstanding		 - - - - - - - - - - 49,011,162.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 49,011,162.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 2.79
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 12.57% 18.02% 15.36% 7.33% 11.73% 81.92% 41.76% 27.42% -18.83% 21.01% 1.82%
EBITDA Growth		 1,082.87% 153.55% 71.87% -11.18% -52.16% 77.60% 351.62% 36.48% -40.43% 38.92% -24.14%
EBIT Growth		 151.30% 407.86% 100.21% -13.07% -108.34% -589.30% 625.84% 53.10% -52.56% 66.59% -31.57%
NOPAT Growth		 131.81% 1,594.87% -25.81% 32.36% -108.17% -428.99% 865.84% 53.02% -51.53% 61.36% -34.80%
Net Income Growth		 109.34% 1,415.83% -25.27% 37.03% -95.76% 1,524.35% 358.82% 56.89% -45.75% 66.45% -32.19%
EPS Growth		 109.23% 1,358.33% -27.43% 37.01% -96.55% 950.00% 353.97% 56.99% -45.21% 65.04% -31.53%
Operating Cash Flow Growth		 347.40% 2,808.02% 40.46% -45.31% -48.29% 484.06% 65.38% -22.01% 25.80% 42.86% 33.64%
Free Cash Flow Firm Growth		 -156.35% 666.48% -96.85% 58.67% -44,268.62% 104.48% 250.00% -28.85% 36.62% 17.54% -302.35%
Invested Capital Growth		 9.07% 9.18% 27.71% 28.52% 405.20% -5.59% 2.66% 14.64% -0.95% 3.35% 36.09%
Revenue Q/Q Growth		 1.62% 8.05% 6.48% -15.02% 44.55% 6.62% 9.82% 2.83% -4.05% 4.78% 0.29%
EBITDA Q/Q Growth		 33.37% 34.99% 60.93% -39.27% 57.65% -34.65% 67.74% 4.26% -16.41% 4.34% -13.47%
EBIT Q/Q Growth		 80.25% 52.85% 77.38% -43.79% -130.08% -117.36% 136.12% 5.96% -24.15% 8.68% -19.28%
NOPAT Q/Q Growth		 4,256.71% 180.41% -28.13% -26.55% -125.82% -134.15% 126.37% 7.69% -25.55% 9.74% -23.18%
Net Income Q/Q Growth		 3,577.22% 182.86% -28.55% -23.73% -90.02% 567.17% 23.22% 9.55% -22.86% 10.10% -21.87%
EPS Q/Q Growth		 0.00% 186.89% -29.83% -26.89% -90.91% 226.00% 22.22% 10.05% -22.88% 10.03% -21.47%
Operating Cash Flow Q/Q Growth		 -86.05% 37.09% 137.95% -73.45% 177.50% 60.33% 9.96% 0.36% 7.56% -2.22% 13.48%
Free Cash Flow Firm Q/Q Growth		 -347.74% 65.86% -88.43% -97.60% -1,087.42% 104.83% 146.24% -13.84% 25.17% -21.80% -257.42%
Invested Capital Q/Q Growth		 1.04% 16.00% 8.37% 54.22% 374.61% -0.70% 0.30% 3.15% -2.60% 2.43% 43.50%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 47.86% 51.61% 52.76% 54.16% 44.14% 50.04% 54.39% 53.64% 51.51% 52.19% 49.72%
EBITDA Margin		 7.93% 17.04% 25.39% 21.01% 9.00% 8.78% 27.98% 29.97% 21.99% 25.25% 18.27%
Operating Margin		 2.65% 13.16% 23.24% 18.66% -1.65% -4.79% 19.83% 23.55% 14.23% 18.95% 13.22%
EBIT Margin		 3.09% 13.29% 23.06% 18.68% -1.39% -5.28% 19.59% 23.54% 13.76% 18.94% 12.73%
Profit (Net Income) Margin		 1.55% 19.91% 12.90% 16.47% 0.62% 5.58% 18.04% 22.22% 14.85% 20.43% 13.60%
Tax Burden Percent		 52.17% 151.14% 55.03% 84.53% -319.93% -115.47% 91.44% 92.45% 91.38% 91.48% 83.95%
Interest Burden Percent		 96.23% 99.15% 101.65% 104.31% 14.00% 91.43% 100.75% 102.12% 118.14% 117.91% 127.34%
Effective Tax Rate		 47.83% -51.14% 44.97% 15.47% 0.00% 0.00% 8.56% 7.55% 8.62% 8.52% 16.05%
Return on Invested Capital (ROIC)		 2.60% 40.33% 25.18% 26.00% -0.62% -2.04% 15.84% 22.29% 10.16% 16.21% 8.81%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.23% 40.28% 24.95% 24.69% -2.82% -16.36% 15.99% 21.44% 7.74% 12.27% 5.43%
Return on Net Nonoperating Assets (RNNOA)		 -1.01% -19.90% -12.17% -11.55% 0.86% 4.49% -5.26% -7.51% -2.89% -5.19% -2.01%
Return on Equity (ROE)		 1.58% 20.43% 13.00% 14.45% 0.23% 2.45% 10.58% 14.78% 7.27% 11.01% 6.79%
Cash Return on Invested Capital (CROIC)		 -6.08% 31.56% 0.84% 1.04% -134.53% 3.72% 13.22% 8.65% 11.11% 12.91% -21.77%
Operating Return on Assets (OROA)		 2.52% 11.23% 19.69% 14.05% -0.46% -2.01% 9.91% 13.74% 6.06% 9.29% 5.71%
Return on Assets (ROA)		 1.27% 16.83% 11.02% 12.39% 0.20% 2.13% 9.13% 12.97% 6.54% 10.02% 6.10%
Return on Common Equity (ROCE)		 1.58% 20.43% 13.00% 14.45% 0.23% 2.45% 10.58% 14.78% 7.27% 11.01% 6.79%
Return on Equity Simple (ROE_SIMPLE)		 1.55% 18.06% 12.54% 12.46% 0.15% 2.45% 9.98% 13.99% 6.98% 10.47% 0.00%
Net Operating Profit after Tax (NOPAT)		 2.59 44 33 43 -3.53 -19 143 219 106 171 112
NOPAT Margin		 1.38% 19.89% 12.79% 15.77% -1.15% -3.36% 18.13% 21.77% 13.00% 17.34% 11.10%
Net Nonoperating Expense Percent (NNEP)		 0.37% 0.06% 0.23% 1.31% 2.20% 14.32% -0.15% 0.85% 2.42% 3.94% 3.37%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 13.71% 6.11% 8.89% 5.31%
Cost of Revenue to Revenue		 52.14% 48.39% 47.24% 45.84% 55.86% 49.96% 45.61% 46.36% 48.49% 47.81% 50.28%
SG&A Expenses to Revenue		 11.98% 10.57% 10.93% 12.31% 17.33% 11.74% 8.61% 6.92% 10.19% 8.69% 10.65%
R&D to Revenue		 17.45% 14.22% 14.78% 14.59% 15.81% 15.20% 12.18% 11.14% 12.80% 11.83% 13.13%
Operating Expenses to Revenue		 45.20% 38.45% 29.52% 35.50% 45.79% 45.24% 34.56% 30.09% 37.28% 33.24% 36.49%
Earnings before Interest and Taxes (EBIT)		 5.79 29 59 51 -4.26 -29 155 237 112 187 128
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 38 65 58 28 49 221 301 179 249 184
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.04 2.56 2.43 1.83 1.45 1.85 3.50 2.11 4.32 4.38 3.87
Price to Tangible Book Value (P/TBV)		 2.17 2.66 2.55 1.99 3.13 3.67 5.99 3.19 5.99 5.74 7.02
Price to Revenue (P/Rev)		 2.04 2.82 2.50 2.42 5.98 4.21 6.32 3.35 9.20 8.54 8.09
Price to Earnings (P/E)		 131.47 14.18 19.38 14.68 957.73 75.58 35.04 15.10 61.94 41.80 59.44
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.76% 7.05% 5.16% 6.81% 0.10% 1.32% 2.85% 6.62% 1.61% 2.39% 1.68%
Enterprise Value to Invested Capital (EV/IC)		 2.87 4.34 3.58 2.61 1.60 2.21 4.89 2.69 6.55 7.06 5.13
Enterprise Value to Revenue (EV/Rev)		 1.60 2.24 2.04 1.78 4.93 3.54 5.68 2.81 8.34 7.67 7.45
Enterprise Value to EBITDA (EV/EBITDA)		 20.11 13.12 8.04 8.46 54.84 40.33 20.28 9.37 37.93 30.40 40.79
Enterprise Value to EBIT (EV/EBIT)		 51.65 16.83 8.85 9.52 0.00 0.00 28.97 11.94 60.65 40.53 58.55
Enterprise Value to NOPAT (EV/NOPAT)		 115.18 11.24 15.96 11.27 0.00 0.00 31.31 12.90 64.17 44.27 67.12
Enterprise Value to Operating Cash Flow (EV/OCF)		 190.23 10.82 8.12 13.87 83.16 18.60 25.54 20.66 39.58 30.84 22.81
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 14.37 479.93 282.69 0.00 57.82 37.52 33.26 58.68 55.57 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.46 -0.49 -0.49 -0.47 -0.30 -0.27 -0.33 -0.35 -0.37 -0.42 -0.37
Leverage Ratio		 1.25 1.21 1.18 1.17 1.15 1.15 1.16 1.14 1.11 1.10 1.11
Compound Leverage Factor		 1.20 1.20 1.20 1.22 0.16 1.05 1.17 1.16 1.31 1.30 1.42
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 5.91 10.23 10.34 8.99 6.60 7.75 14.88 12.12 27.69 28.39 19.84
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.94 5.15 5.45 7.80 7.48 6.09 6.14 7.07 8.69 8.69 5.79
Quick Ratio		 2.67 4.03 4.07 5.32 5.18 4.35 4.46 4.92 6.26 6.82 4.15
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -6.07 34 1.09 1.72 -761 34 119 85 116 136 -276
Operating Cash Flow to CapEx		 85.10% 1,142.41% 628.51% 465.31% 266.77% 2,767.93% 1,455.94% 742.75% 869.74% 770.07% 1,151.46%
Free Cash Flow to Firm to Interest Expense		 -21.02 120.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 5.44 160.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -0.95 146.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.82 0.85 0.85 0.75 0.33 0.38 0.51 0.58 0.44 0.49 0.45
Accounts Receivable Turnover		 5.86 5.72 5.01 4.32 3.26 4.08 4.83 4.80 3.49 3.69 3.48
Inventory Turnover		 2.23 2.33 2.52 1.66 1.25 1.51 1.66 1.64 1.21 1.54 1.73
Fixed Asset Turnover		 3.98 4.98 5.73 8.60 5.22 5.97 9.28 11.55 8.34 8.68 8.01
Accounts Payable Turnover		 8.93 9.30 9.56 8.14 7.64 8.19 7.69 8.64 7.58 8.90 6.17
Days Sales Outstanding (DSO)		 62.29 63.79 72.91 84.42 112.07 89.50 75.52 76.00 104.68 98.84 104.76
Days Inventory Outstanding (DIO)		 163.67 156.74 144.92 219.88 291.54 241.12 220.29 222.23 300.80 237.69 211.29
Days Payable Outstanding (DPO)		 40.86 39.26 38.16 44.84 47.76 44.58 47.44 42.25 48.16 41.03 59.19
Cash Conversion Cycle (CCC)		 185.11 181.27 179.67 259.47 355.85 286.04 248.38 255.98 357.32 295.49 256.87
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 104 114 145 187 944 891 915 1,049 1,039 1,074 1,461
Invested Capital Turnover		 1.88 2.03 1.97 1.65 0.54 0.61 0.87 1.02 0.78 0.93 0.79
Increase / (Decrease) in Invested Capital		 8.67 9.57 32 41 757 -53 24 134 -9.92 35 387
Enterprise Value (EV)		 299 494 521 487 1,509 1,971 4,477 2,824 6,807 7,577 7,490
Market Capitalization		 382 624 638 662 1,829 2,345 4,988 3,372 7,504 8,429 8,129
Book Value per Share		 $7.74 $9.78 $10.25 $14.94 $25.25 $25.90 $28.94 $32.24 $35.38 $38.99 $42.86
Tangible Book Value per Share		 $7.28 $9.41 $9.77 $13.71 $11.68 $13.10 $16.90 $21.37 $25.54 $29.73 $23.64
Total Capital		 187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -83 -130 -117 -175 -320 -374 -511 -548 -698 -852 -640
Capital Expenditures (CapEx)		 1.85 4.00 10 7.54 6.80 3.83 12 18 20 32 29
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 50 44 79 131 236 238 282 427 438 455 409
Debt-free Net Working Capital (DFNWC)		 133 174 196 306 556 612 794 974 1,136 1,307 1,049
Net Working Capital (NWC)		 133 174 196 306 556 612 794 974 1,136 1,307 1,049
Net Nonoperating Expense (NNE)		 -0.31 -0.06 -0.28 -1.91 -5.44 -50 0.66 -4.50 -15 -31 -25
Net Nonoperating Obligations (NNO)		 -83 -130 -117 -175 -320 -374 -511 -548 -698 -852 -640
Total Depreciation and Amortization (D&A)		 9.08 8.30 5.93 6.38 32 78 66 65 67 62 56
Debt-free, Cash-free Net Working Capital to Revenue		 26.59% 20.08% 30.96% 47.79% 77.05% 42.74% 35.77% 42.43% 53.65% 46.09% 40.73%
Debt-free Net Working Capital to Revenue		 70.93% 78.85% 76.84% 111.74% 181.74% 109.90% 100.59% 96.93% 139.18% 132.42% 104.36%
Net Working Capital to Revenue		 70.93% 78.85% 76.84% 111.74% 181.74% 109.90% 100.59% 96.93% 139.18% 132.42% 104.36%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.12 $1.79 $1.19 $2.39 $0.06 $0.63 $2.89 $0.00 $2.47 $4.09 $2.78
Adjusted Weighted Average Basic Shares Outstanding		 24.06M 24.66M 25.33M 24.12M 29.73M 49.14M 49.24M 0.00 48.97M 49.34M 49.12M
Adjusted Diluted Earnings per Share		 $0.12 $1.75 $1.17 $2.34 $0.06 $0.63 $2.86 $0.00 $2.46 $4.06 $2.78
Adjusted Weighted Average Diluted Shares Outstanding		 24.38M 25.15M 25.92M 24.60M 30.01M 49.48M 49.73M 0.00 49.32M 49.66M 49.27M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 24.30M 25.16M 23.76M 24.46M 50.28M 48.88M 49.36M 0.00 49.13M 49.27M 49.70M
Normalized Net Operating Profit after Tax (NOPAT)		 3.31 20 25 43 -3.53 -19 143 219 106 171 112
Normalized NOPAT Margin		 1.77% 9.21% 9.99% 15.77% -1.15% -3.36% 18.13% 21.77% 13.00% 17.34% 11.10%
Pre Tax Income Margin		 2.97% 13.18% 23.44% 19.48% -0.20% -4.83% 19.73% 24.03% 16.25% 22.33% 16.20%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 20.02 103.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 8.98 154.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 13.63 89.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 2.59 140.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 29.29% 0.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 88.54% 0.72% 3.11% 46.72% 38.95% 167.61% 0.00% 29.22% 2.64% 12.43% 54.85%

Quarterly Metrics And Ratios for Onto Innovation

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - 49,011,162.00 49,702,361.00 49,743,567.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 49,011,162.00 49,702,361.00 49,743,567.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - 0.21 0.68 1.21
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -13.59% 14.90% 27.10% 21.73% 20.60% 16.50% 4.65% -13.49% 1.11% 9.51% 35.30%
EBITDA Growth		 -44.41% 31.95% 64.28% 38.63% 23.52% 26.09% -30.94% -48.38% -40.64% -21.02% 80.55%
EBIT Growth		 -56.62% 51.39% 111.17% 58.61% 54.57% 43.33% -36.21% -56.66% -72.25% -47.19% 103.31%
NOPAT Growth		 -59.09% 50.12% 95.77% 46.33% 59.83% 43.52% -39.05% -54.69% -81.52% -47.36% 102.65%
Net Income Growth		 -54.23% 61.18% 104.47% 47.83% 61.06% 36.80% -35.96% -46.80% -78.43% -47.34% 77.23%
EPS Growth		 -54.48% 59.32% 101.89% 46.58% 60.66% 38.30% -35.51% -46.73% -77.55% -48.46% 75.36%
Operating Cash Flow Growth		 24.43% 14.11% 106.07% 134.87% -9.07% 61.00% -11.27% 24.01% 69.64% -71.38% 6.15%
Free Cash Flow Firm Growth		 148.84% 147.15% 213.41% 452.82% -84.10% -29.50% -89.64% -21.10% -6,888.44% -1,450.72% -8,135.55%
Invested Capital Growth		 -0.95% -0.05% -0.14% -1.72% 3.35% 2.73% 2.17% -2.86% 36.09% 38.26% 41.55%
Revenue Q/Q Growth		 5.63% 4.56% 5.89% 4.08% 4.65% 1.01% -4.88% -13.96% 22.31% 0.00% 17.53%
EBITDA Q/Q Growth		 -11.87% 36.15% 8.97% 6.02% -21.48% 35.32% -40.42% -20.72% -10.29% 0.00% 55.00%
EBIT Q/Q Growth		 -17.07% 59.05% 12.04% 7.33% -19.18% 47.48% -50.14% -27.07% -48.25% 0.00% 91.96%
NOPAT Q/Q Growth		 -19.79% 55.55% 14.75% 2.20% -12.39% 39.68% -51.27% -24.02% -64.26% 0.00% 87.59%
Net Income Q/Q Growth		 -15.54% 54.58% 13.01% 0.19% -7.98% 31.30% -47.09% -16.77% -62.69% 0.00% 78.08%
EPS Q/Q Growth		 -16.44% 54.10% 13.83% 0.00% -8.41% 32.65% -46.92% -17.39% -61.40% 0.00% 80.60%
Operating Cash Flow Q/Q Growth		 115.10% -7.23% 14.30% 2.98% -16.73% 64.25% -37.00% 43.93% 13.91% 0.00% 133.67%
Free Cash Flow Firm Q/Q Growth		 292.61% 13.12% 17.03% 38.37% -91.32% 401.64% -82.80% 953.53% -846.71% 0.00% -2.34%
Invested Capital Q/Q Growth		 -2.60% 0.18% 0.48% 0.24% 2.43% -0.42% -0.06% -4.70% 43.50% 0.00% 2.31%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 49.33% 51.69% 52.92% 54.07% 50.17% 53.72% 48.16% 50.70% 46.39% 50.14% 53.41%
EBITDA Margin		 20.15% 26.23% 27.00% 27.50% 20.63% 27.64% 17.31% 15.95% 11.70% 19.94% 26.29%
Operating Margin		 12.90% 18.68% 20.15% 21.04% 16.09% 23.68% 12.72% 10.86% 5.19% 11.48% 18.52%
EBIT Margin		 12.51% 19.02% 20.13% 20.76% 16.03% 23.40% 12.27% 10.40% 4.40% 11.29% 18.43%
Profit (Net Income) Margin		 13.85% 20.47% 21.85% 21.03% 18.50% 24.04% 13.37% 12.94% 3.95% 11.56% 17.52%
Tax Burden Percent		 89.60% 92.06% 92.46% 86.95% 95.21% 89.45% 85.33% 88.26% 53.93% 88.69% 87.75%
Interest Burden Percent		 123.59% 116.91% 117.42% 116.56% 121.19% 114.85% 127.74% 140.95% 166.30% 115.48% 108.29%
Effective Tax Rate		 10.40% 7.94% 7.54% 13.05% 4.79% 10.55% 14.67% 11.74% 46.07% 11.31% 12.25%
Return on Invested Capital (ROIC)		 9.03% 13.97% 15.98% 16.31% 14.32% 20.58% 10.64% 9.30% 2.22% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.23% 12.83% 14.86% 15.38% 13.24% 19.63% 9.88% 8.50% 1.81% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -3.08% -4.99% -5.94% -6.34% -5.60% -8.44% -4.38% -4.00% -0.67% 0.00% 0.00%
Return on Equity (ROE)		 5.96% 8.98% 10.03% 9.96% 8.72% 12.14% 6.26% 5.29% 1.55% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 11.11% 11.50% 13.64% 16.49% 12.91% 15.16% 13.99% 16.96% -21.77% -32.12% -34.40%
Operating Return on Assets (OROA)		 5.51% 8.56% 9.44% 9.94% 7.86% 11.79% 6.13% 4.89% 1.97% 0.00% 0.00%
Return on Assets (ROA)		 6.10% 9.22% 10.25% 10.07% 9.07% 12.11% 6.69% 6.09% 1.77% 0.00% 0.00%
Return on Common Equity (ROCE)		 5.96% 8.98% 10.03% 9.96% 8.72% 12.14% 6.26% 5.29% 1.55% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 7.80% 9.06% 9.62% 0.00% 11.40% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 25 39 45 46 40 56 28 21 7.47 30 56
NOPAT Margin		 11.56% 17.19% 18.63% 18.30% 15.32% 21.18% 10.85% 9.58% 2.80% 10.18% 16.25%
Net Nonoperating Expense Percent (NNEP)		 0.81% 1.13% 1.12% 0.93% 1.08% 0.96% 0.76% 0.80% 0.41% 0.54% 0.66%
Return On Investment Capital (ROIC_SIMPLE)		 1.46% - - - 2.10% 2.94% 1.40% 1.04% 0.36% 1.39% 1.64%
Cost of Revenue to Revenue		 50.67% 48.31% 47.08% 45.93% 49.83% 46.28% 54.30% 51.17% 49.75% 51.64% 47.69%
SG&A Expenses to Revenue		 12.34% 7.67% 8.37% 8.91% 9.68% 8.97% 9.86% 11.38% 12.92% 10.76% 9.98%
R&D to Revenue		 10.98% 11.60% 11.16% 11.21% 13.22% 10.51% 13.92% 14.89% 13.55% 12.02% 11.33%
Operating Expenses to Revenue		 36.43% 33.01% 32.77% 33.03% 34.08% 30.04% 32.99% 37.98% 45.05% 36.88% 33.79%
Earnings before Interest and Taxes (EBIT)		 27 44 49 52 42 62 31 23 12 33 63
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 44 60 65 69 54 74 44 35 31 58 90
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.32 4.99 5.91 5.59 4.38 3.13 2.46 3.12 3.87 4.78 9.79
Price to Tangible Book Value (P/TBV)		 5.99 6.78 7.87 7.29 5.74 4.09 3.17 3.98 7.02 8.42 18.45
Price to Revenue (P/Rev)		 9.20 10.51 12.06 11.29 8.54 5.87 4.66 6.24 8.09 0.00 0.00
Price to Earnings (P/E)		 61.94 63.97 65.18 58.07 41.80 27.47 24.18 35.72 59.44 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 1.61% 1.56% 1.53% 1.72% 2.39% 3.64% 4.14% 2.80% 1.68% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 6.55 7.83 9.60 9.33 7.06 4.83 3.69 5.17 5.13 6.45 12.18
Enterprise Value to Revenue (EV/Rev)		 8.34 9.63 11.18 10.38 7.67 5.04 3.80 5.26 7.45 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 37.93 42.00 45.69 40.94 30.40 19.52 16.08 24.82 40.79 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 60.65 64.15 65.71 56.86 40.53 25.09 20.93 33.24 58.55 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 64.17 68.34 71.00 62.70 44.27 27.42 23.08 36.26 67.12 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 39.58 45.50 47.18 38.92 30.84 18.41 14.42 18.21 22.81 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 58.68 68.06 70.27 56.10 55.57 32.29 26.62 30.06 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.77
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.77
Financial Leverage		 -0.37 -0.39 -0.40 -0.41 -0.42 -0.43 -0.44 -0.47 -0.37 -0.37 -0.34
Leverage Ratio		 1.11 1.10 1.10 1.09 1.10 1.10 1.09 1.09 1.11 1.11 1.50
Compound Leverage Factor		 1.37 1.29 1.29 1.27 1.33 1.26 1.40 1.54 1.85 1.29 1.63
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 43.36%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 43.36%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 56.64%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 27.54 32.65 39.04 39.30 28.16 20.23 18.13 22.05 19.67 24.20 7.50
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.69 9.06 9.33 10.07 8.69 8.42 9.59 9.49 5.79 6.15 9.73
Quick Ratio		 6.26 6.62 6.90 7.66 6.82 6.55 7.58 7.64 4.15 4.48 8.17
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 35 40 47 65 5.60 28 4.83 51 -380 -379 -388
Operating Cash Flow to CapEx		 2,500.45% 819.08% 532.92% 835.47% 1,210.53% 1,117.21% 420.73% 6,047.57% 1,852.13% 734.23% 1,681.90%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.44 0.45 0.47 0.48 0.49 0.50 0.50 0.47 0.45 0.00 0.00
Accounts Receivable Turnover		 3.49 3.83 4.22 4.07 3.69 3.92 3.96 3.90 3.48 0.00 0.00
Inventory Turnover		 1.21 1.23 1.30 1.38 1.54 1.56 1.72 1.77 1.73 0.00 0.00
Fixed Asset Turnover		 8.34 8.27 8.33 8.40 8.68 8.76 8.34 8.05 8.01 0.00 0.00
Accounts Payable Turnover		 7.58 7.52 8.63 9.76 8.90 8.71 11.40 9.95 6.17 0.00 0.00
Days Sales Outstanding (DSO)		 104.68 95.29 86.59 89.72 98.84 93.19 92.13 93.57 104.76 0.00 0.00
Days Inventory Outstanding (DIO)		 300.80 295.85 281.28 264.57 237.69 234.20 211.75 206.34 211.29 0.00 0.00
Days Payable Outstanding (DPO)		 48.16 48.55 42.28 37.38 41.03 41.89 32.03 36.68 59.19 0.00 0.00
Cash Conversion Cycle (CCC)		 357.32 342.59 325.58 316.91 295.49 285.51 271.85 263.23 256.87 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,039 1,041 1,046 1,048 1,074 1,069 1,068 1,018 1,461 1,478 1,512
Invested Capital Turnover		 0.78 0.81 0.86 0.89 0.93 0.97 0.98 0.97 0.79 0.00 0.00
Increase / (Decrease) in Invested Capital		 -9.92 -0.49 -1.47 -18 35 28 23 -30 387 409 444
Enterprise Value (EV)		 6,807 8,147 10,033 9,780 7,577 5,164 3,938 5,268 7,490 9,538 18,415
Market Capitalization		 7,504 8,888 10,819 10,636 8,429 6,014 4,833 6,252 8,129 10,192 18,825
Book Value per Share		 $35.38 $36.19 $37.17 $38.55 $38.99 $38.96 $40.17 $40.86 $42.86 $42.90 $38.65
Tangible Book Value per Share		 $25.54 $26.64 $27.90 $29.56 $29.73 $29.85 $31.15 $32.04 $23.64 $24.35 $20.52
Total Capital		 1,737 1,782 1,832 1,904 1,926 1,920 1,963 2,002 2,101 2,132 3,394
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,472
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,472
Net Debt		 -698 -741 -786 -855 -852 -851 -895 -984 -640 -654 -410
Capital Expenditures (CapEx)		 2.46 6.98 12 8.05 4.63 8.23 14 1.38 5.13 3.59 3.66
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 438 445 451 458 455 444 444 398 409 451 488
Debt-free Net Working Capital (DFNWC)		 1,136 1,186 1,237 1,313 1,307 1,295 1,339 1,382 1,049 1,105 2,370
Net Working Capital (NWC)		 1,136 1,186 1,237 1,313 1,307 1,295 1,339 1,382 1,049 1,105 2,370
Net Nonoperating Expense (NNE)		 -5.01 -7.51 -7.80 -6.91 -8.39 -7.62 -6.39 -7.32 -3.06 -4.02 -4.34
Net Nonoperating Obligations (NNO)		 -698 -741 -786 -855 -852 -851 -895 -984 -640 -654 -410
Total Depreciation and Amortization (D&A)		 17 17 17 17 12 11 13 12 19 25 27
Debt-free, Cash-free Net Working Capital to Revenue		 53.65% 52.61% 50.24% 48.59% 46.09% 43.33% 42.81% 39.72% 40.73% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 139.18% 140.24% 137.85% 139.37% 132.42% 126.31% 129.17% 137.88% 104.36% 0.00% 0.00%
Net Working Capital to Revenue		 139.18% 140.24% 137.85% 139.37% 132.42% 126.31% 129.17% 137.88% 104.36% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.61 $0.95 $1.07 $1.07 $1.00 $1.30 $0.69 $0.58 $0.21 $0.68 $1.22
Adjusted Weighted Average Basic Shares Outstanding		 48.97M 49.23M 49.34M 49.43M 49.34M 49.18M 48.93M 49.02M 49.12M 49.74M 49.41M
Adjusted Diluted Earnings per Share		 $0.61 $0.94 $1.07 $1.07 $0.98 $1.30 $0.69 $0.57 $0.22 $0.67 $1.21
Adjusted Weighted Average Diluted Shares Outstanding		 49.32M 49.64M 49.67M 49.69M 49.66M 49.41M 49.02M 49.11M 49.27M 50.00M 49.68M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 49.13M 49.28M 49.38M 49.39M 49.27M 48.87M 49.00M 49.01M 49.70M 49.74M 49.07M
Normalized Net Operating Profit after Tax (NOPAT)		 25 39 45 46 40 56 28 21 7.47 30 56
Normalized NOPAT Margin		 11.56% 17.19% 18.63% 18.30% 15.32% 21.18% 10.85% 9.58% 2.80% 10.18% 16.25%
Pre Tax Income Margin		 15.46% 22.24% 23.63% 24.19% 19.43% 26.88% 15.67% 14.66% 7.32% 13.03% 19.96%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 2.64% 0.00% 0.00% 0.00% 12.43% 45.72% 50.07% 57.18% 54.85% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Onto Innovation’s latest results show a sharp acceleration in revenue and profitability, although the balance sheet now reflects materially higher debt and the cash-flow data contains an apparent classification inconsistency. Revenue increased from $190.7 million in Q2 2023 to $343.1 million in Q2 2026, an approximately 80% rise. Q2 2026 revenue also grew 35% year over year and 18% sequentially from Q1 2026.

Profitability has improved meaningfully from the Q4 2025 trough. Q2 2026 gross profit was $183.3 million, producing a 53.4% gross margin compared with 48.2% in Q2 2025. Operating income rose to $63.6 million from $33.5 million in Q1 2026, while net income reached $60.1 million, or $1.21 per diluted share. That compares with $33.8 million of net income and $0.67 of diluted EPS in the prior quarter.

The longer-term earnings trend is positive but uneven. Net income increased from $30.3 million in Q4 2023 to $48.8 million in Q4 2024, fell to $10.5 million in Q4 2025, and then recovered to $60.1 million in Q2 2026. Investors should distinguish the strong current rebound from a consistently stable earnings trajectory.

  • Revenue growth has accelerated: Q2 2026 revenue of $343.1 million was up 35% year over year and approximately 80% above Q2 2023.
  • Margins recovered: Gross margin improved to 53.4% in Q2 2026 from 48.2% in Q2 2025, while operating margin increased to approximately 18.5% from 13.2%.
  • EPS momentum is strong: Diluted EPS rose to $1.21 in Q2 2026 from $0.67 in Q1 and $0.69 in Q2 2025.
  • Operating cash flow remains positive: Reported cash flow from operating activities was $61.5 million in Q2 2026, following $26.3 million in Q1 and $57.9 million in Q2 2025.
  • Liquidity is substantial: Cash and short-term investments totaled approximately $1.88 billion at the end of Q2 2026, providing flexibility for investment, acquisitions, or shareholder returns.
  • Current liquidity remains strong: Current assets of $2.64 billion substantially exceeded current liabilities of $271.6 million, implying a current ratio of nearly 10 times.
  • Share repurchases may support per-share results: Onto Innovation repurchased approximately $205.0 million of common stock in Q2 2026, which can enhance EPS if operating performance remains strong.
  • Cash deployment is heavily concentrated in investments: The company purchased $472.6 million of investments and sold or received maturities of $246.1 million in Q2 2026. This appears primarily to be treasury portfolio management rather than core capital investment.
  • Debt increased sharply: Q2 2026 long-term debt was reported at $1.47 billion, compared with no long-term debt shown in the earlier balance sheets provided. Total liabilities rose to $1.78 billion from $264.2 million in Q1 2026.
  • Cash-flow classifications require caution: The Q2 2026 statement reports $1.17 billion of net financing cash inflow and $1.25 billion of net change in cash, but the listed financing components do not appear to reconcile to that total. Investors should verify the company’s filing before relying on the reported cash increase.

Overall, the income statement points to strong operating momentum, with revenue, margins, net income, and EPS all improving substantially in the latest quarter. The main risks are the newly reported debt burden, the sustainability of the rebound after a weak Q4 2025, and the need to clarify the Q2 2026 cash-flow presentation.

09/12/26 03:48 AM ETAI Generated. May Contain Errors.

Onto Innovation Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Onto Innovation's fiscal year ends in January. Their fiscal year 2026 ended on January 3, 2026.

Onto Innovation's net income appears to be on an upward trend, with a most recent value of $136.76 million in 2025, rising from $2.91 million in 2015. The previous period was $201.67 million in 2024. Check out Onto Innovation's forecast to explore projected trends and price targets.

Onto Innovation's total operating income in 2025 was $132.93 million, based on the following breakdown:
  • Total Gross Profit: $499.77 million
  • Total Operating Expenses: $366.84 million

Over the last 10 years, Onto Innovation's total revenue changed from $187.37 million in 2015 to $1.01 billion in 2025, a change of 436.5%.

Onto Innovation's total liabilities were at $267.09 million at the end of 2025, a 39.7% increase from 2024, and a 454.0% increase since 2015.

In the past 10 years, Onto Innovation's cash and equivalents has ranged from $34.90 million in 2017 to $346.12 million in 2025, and is currently $346.12 million as of their latest financial filing in 2025.

Over the last 10 years, Onto Innovation's book value per share changed from 7.74 in 2015 to 42.86 in 2025, a change of 453.4%.


Related Companies

Financial statements for NYSE:ONTO last updated on 9/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Elon Musk to Trigger Next AI Wave on November 11th?
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
Bezos… DOOMED
A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...
Paradigm Press | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
This metric called 1929, 1969 and 2000 [it's screaming now]
The Buffett Indicator once flagged the 1929, 1969, and 2000 market peaks - and it's now at 231%, its highest r...
Golden Portfolio | Sponsoredtc pixel
How options let you do more with less capital
Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...
Base Camp Trading | Sponsoredtc pixel
The retirement income that answers “yes” when everything else says no
Todd Phillips has spent 30 years studying safe-money income. He says most so-called income sources fail one te...
Eagle Publishing | Sponsoredtc pixel
Elon’s “nude” scandal – a big opportunity?
Louis Navellier, the quantitative analyst who called Nvidia before its 44,000% run, says Elon Musk's AI ambiti...
InvestorPlace | Sponsoredtc pixel